Protective effect of L-cysteine and glutathione on the modulated suckling rat brain Na+,K+-ATPase and Mg2+-ATPase activities induced by the in vitro galactosaemia

Pharmacological Research

Volumn 49, Issue 5, 2004, Pages 475-479

  Tsakiris, Stylianos ^a   Schulpis, Kleopatra H ^b   Marinou, Kyriakoula ^a   Behrakis, Panagiotis ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Brain Mg2+ ATPase; Brain Na +,K+ ATPase; Free radicals; Galactosaemia; Glutathione; L Cysteine

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); ADENOSINE TRIPHOSPHATE MAGNESIUM; ANTIOXIDANT; BRAIN ENZYME; CYSTEINE; FREE RADICAL; GALACTITOL; GALACTOSE; GLUTATHIONE; NEUROPROTECTIVE AGENT; PHOSPHATE; PROTECTIVE AGENT;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN; BRAIN HOMOGENATE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME INHIBITION; FEMALE; GALACTOSEMIA; INCUBATION TIME; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPECTROPHOTOMETRY;

ANIMALS; ANIMALS, SUCKLING; ANTIOXIDANTS; BRAIN; BRAIN DISEASES, METABOLIC, INBORN; CA(2+) MG(2+)-ATPASE; CYSTEINE; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; FEMALE; GALACTITOL; GALACTOSE; GALACTOSEMIAS; GALACTOSEPHOSPHATES; GLUTATHIONE; MALE; NA(+)-K(+)-EXCHANGING ATPASE; RATS; RATS, WISTAR;

EID: 1442358003     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2003.11.006     Document Type: Article

References (23)

1. Gitzelmann R. Galactose 1-phosphate in the pathophysiology of galactosemia. Eur. J. Paediatr. 154:1995;545-549.
2. Schulpis K.H., Papakonstantinou E.D., Michelakakis H., Podskarbi T., Patsouras A., Shin Y. Screening for galactosemia in Greece. Pediatr. Perinatal Epidemiol. 11:1997;436-440.
3. Berry GT, Segal S. Disorder of galactose metabolism. In: Scriver CR, Beadet AL, Sly WS, Valle D, editors. Metabolic and molecular basis of inherited diseases. New York: McGraw Hill; 2000. p. 1553-89.
4. +-ATPase activity. Z Naturforsch. 57c:2002;939-943.
5. 2+-ATPase activity. Pharmacol. Toxicol. 91:2002;254-257.
6. Floyd RA, Zaleska MM, Harmon J. Free radicals in molecular biology, aging and disease. In: Armstrong D, Sohal RS, Cutler RG, Slater TF, editors. Aging. New York: Raven Press; 1984. p. 143-61.
7. Hall E.D., Braughler J.M. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence of oxygen radicals and lipid peroxidation. Free Radic. Biol. Med. 6:1989;303-313.
8. Benzi G., Pastoris D., Mazzatico F., Villa R.F. Age related effect induced by oxidative stress on the cerebral glutathione system. Neurochem. Res. 14:1989;473-481.
9. Committee on Care and Use of Laboratory Animals. Guide for the care and use of laboratory animals. Washington, DC: Institute of Laboratory Animal Resources, National Research Council; 1985. p. 83.
10. Lowry O.H., Rosebrough N.J., Farr A.L., Randall A.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
11. Murakami M., Webb M.A. A morphological and biochemical study of the effects of L-cysteine on the renal uptake and nephrotoxicity of cadmium. Br. J. Exp. Pathol. 62:1981;115-130.
12. Bowler K., Tirri R. The temperature characteristics of synaptic membrane ATPases from immature and adult rat brain. J. Neurochem. 23:1974;611-613.
13. +-ATPase inhibition induced by free radicals. Z. Naturforsch. 55:2000;271-277.
14. Sweadner K.J., Goldin S.M. Active transport of sodium and potassium ions: mechanism, function and regulation. N. Engl. J. Med. 302:1980;777-783.
15. +-ATPase inhibitors. Can. J. Physiol. Pharmacol. 55:1977;170-180.
16. Mata M., Fink D.J., Gainer H., Smith C.B., Davidsen L., Savakis H.et al. Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J. Neurochem. 34:1980;213-215.
17. Bogdanski D.F., Tissuri A., Brodie B.B. Role of sodium, potassium, ouabain and reserpine in uptake, storage and metabolism of biogenic amines in synaptosomes. Life Sci. 7:1968;419-428.
18. Herrero E., Aragon M.C., Gimenez C., Valdivieso F. Inhibition by L-phenylalanine of tryptophan transport by synaptosomal plasma membrane vesicles: implications in the pathogenesis of phenylketonuria. J. Inherit. Metab. Dis. 6:1983;32-35.
19. Kowluru R.A., Engerman R.E., Kern T.S. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VI. Comparison of retinal and cerebral cortex metabolism and effects of antioxidant therapy. Free Radic. Biol. Med. 26:1999;371-378.
20. Figeolet E., Corbister P., Houbion A., Lambert D., Michiels C., Raes M. Glutathione peroxidase, superoxide dismutate and catalase inactivation by peroxides and oxygen derived free radicals. Mech. Age Dev. 51:1990;283-297.
21. Sanui H, Rubin H. The role of magnesium in cell proliferation and transformation. In: Boyton AL, McKeehan WL, Whitfield JP, editors. Ions, cell proliferation and cancer. New York: Academic Press; 1982. p. 517-37.
22. Tappel A.L. Lipid peroxidation damage to cell components. Fed. Proc. 32:1973;1870-1874.
23. Regan R.F., Guo Y. Magnesium deprivation decreases cellular reduced glutathione and causes oxidative neuronal death in murine cortical cultures. Brain Res. 890:2001;177-183.